Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2003
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444583A Method for preparing arylacetyl aminothiazole
09/24/2003CN1444582A Heterocyclic compound, their preparation and use
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444571A Urethane derivatives
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons
09/24/2003CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex
09/24/2003CN1443845A UBF antisense nucleotide and its derivative, its preparation and application
09/24/2003CN1443777A Monoclonal antibody capable of identifying tumor cell surface antigen and its preparation and application
09/24/2003CN1443772A Narcissus seed glycopeptide and its application
09/24/2003CN1443761A 2-aryl substitutled benzo[b] furan compound, its preparation method and application
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1443556A Chinese medicine preparation for curing cancers
09/24/2003CN1443537A Application of emodin analog EMD-31 for curing tumor
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1122031C Substituted benzocycloheptapyridine derivatives useful for inhibitino of farnesyl protein transferase
09/24/2003CN1121874C Immunotherapeutic agent and its use
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624169 Urokinase inhibitors
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624166 Pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta protease activity in a mammal utilizing the compounds and compositions for enzyme inhibitors
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624157 Antitumor agents
09/23/2003US6624147 Inhibitors of prenylated pyrophosphate consuming enzymes
09/23/2003US6624144 Matrix metalloproteinase inhibitors and down-regulators
09/23/2003US6624142 Trimethyl lock based tetrapartate prodrugs
09/23/2003US6623962 Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003US6623721 Conjugates can be complexed to a radioisotope metallic element and used for diagnosing or treating receptor-positive tumors
09/23/2003US6623453 Chemo-thermo applicator for cancer treatment
09/23/2003CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
09/21/2003CA2422623A1 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (cns) and/or in other parenchymal organs
09/19/2003WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/19/2003CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/18/2003WO2003076948A1 Use of the mal protein as a tumour marker
09/18/2003WO2003076639A1 Osteoclast differentiation inhibitors
09/18/2003WO2003076638A1 Angiogenesis inhibitors
09/18/2003WO2003076631A2 Genetic products differentially expressed in tumors and use thereof
09/18/2003WO2003076623A1 Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003WO2003076579A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076571A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076490A1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound
09/18/2003WO2003076473A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
09/18/2003WO2003076472A2 Neoplasm specific antibodies and uses thereof
09/18/2003WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/18/2003WO2003076465A2 Downregulation of ca 125 tumor antigen and uses thereof
09/18/2003WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076445A2 Microtubule stabilizing compounds
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076418A1 Quinazolinone modulators of nuclear receptors
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076412A1 Novel hairpin polyamide
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076404A1 Chain oligolactic acid thioester
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076391A2 Urokinase inhibitors, production and use thereof
09/18/2003WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
09/18/2003WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
09/18/2003WO2003075958A1 Remedies for sex hormone-dependent disease
09/18/2003WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003WO2003075956A2 Use of mixtures of lipopeptides for vaccine production
09/18/2003WO2003075954A1 Fuel additive
09/18/2003WO2003075952A1 Methods of enhancing immune induction involving mda-7
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 2211